Literature DB >> 23403083

Cell-SELEX based selection and characterization of DNA aptamer recognizing human hepatocarcinoma.

Kazuaki Ninomiya1, Kazuhiko Kaneda, Satoshi Kawashima, Yusuke Miyachi, Chiaki Ogino, Nobuaki Shimizu.   

Abstract

Single-stranded DNA aptamers recognizing human hepatocarcinoma were isolated by means of a systematic evolution of ligands by exponential enrichment using whole cells as targets (cell-SELEX). After 11 rounds of cell-SELEX procedure using human hepatoma HepG2 cells as targets and human normal hepatocyte cells as counterparts, 12 independent DNA aptamer candidate sequences were obtained. The specific interaction between selected DNA aptamers and targeted cell was confirmed. Dissociation constants of the 12 sequences obtained were also estimated in the range of 19-450nM. Moreover, the consensus secondary structure was found in the isolated aptamers, which was responsible to the recognition of HepG2 cells.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23403083     DOI: 10.1016/j.bmcl.2013.01.040

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  11 in total

Review 1.  Recent advances in understanding oligonucleotide aptamers and their applications as therapeutic agents.

Authors:  Khaled S Allemailem; Ahmad Almatroudi; Mohammed A Alsahli; Ghaiyda Talal Basfar; Faris Alrumaihi; Arshad Husain Rahmani; Amjad Ali Khan
Journal:  3 Biotech       Date:  2020-11-24       Impact factor: 2.406

Review 2.  Research progress of whole-cell-SELEX selection and the application of cell-targeting aptamer.

Authors:  Yu Duan; Chunyun Zhang; Yuanyuan Wang; Guofu Chen
Journal:  Mol Biol Rep       Date:  2022-03-10       Impact factor: 2.742

Review 3.  Development of Cell-SELEX Technology and Its Application in Cancer Diagnosis and Therapy.

Authors:  Man Chen; Yuanyuan Yu; Feng Jiang; Junwei Zhou; Yongshu Li; Chao Liang; Lei Dang; Aiping Lu; Ge Zhang
Journal:  Int J Mol Sci       Date:  2016-12-10       Impact factor: 5.923

4.  Catch-and-Release of Target Cells Using Aptamer-Conjugated Electroactive Zwitterionic Oligopeptide SAM.

Authors:  Junko Enomoto; Tatsuto Kageyama; Tatsuya Osaki; Flavia Bonalumi; Francesca Marchese; Alfonso Gautieri; Elena Bianchi; Gabriele Dubini; Chiara Arrigoni; Matteo Moretti; Junji Fukuda
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

Review 5.  Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures.

Authors:  Kamal Rahimizadeh; Hadi AlShamaileh; Milena Fratini; Madhuri Chakravarthy; Michelle Stephen; Sarah Shigdar; Rakesh N Veedu
Journal:  Molecules       Date:  2017-11-27       Impact factor: 4.411

Review 6.  Aptamers: novelty tools for cancer biology.

Authors:  Ricardo L Pereira; Isis C Nascimento; Ana P Santos; Isabella E Y Ogusuku; Claudiana Lameu; Günter Mayer; Henning Ulrich
Journal:  Oncotarget       Date:  2018-06-01

7.  Selection and Characterization of a Novel DNA Aptamer, Apt-07S Specific to Hepatocellular Carcinoma Cells.

Authors:  Xiao-Xia Yu; Ke-Li Ge; Ning Liu; Jin-Yu Zhang; Mei-Lan Xue; Yin-Lin Ge
Journal:  Drug Des Devel Ther       Date:  2020-04-20       Impact factor: 4.162

8.  Subtractive Cell-SELEX Selection of DNA Aptamers Binding Specifically and Selectively to Hepatocellular Carcinoma Cells with High Metastatic Potential.

Authors:  Hao Chen; Chun-Hui Yuan; Yi-Fei Yang; Chang-Qing Yin; Qing Guan; Fu-Bing Wang; Jian-Cheng Tu
Journal:  Biomed Res Int       Date:  2016-03-28       Impact factor: 3.411

9.  Selection and characterization of DNA aptamer for metastatic prostate cancer recognition and tissue imaging.

Authors:  Minlan Duan; Yuqian Long; Cai Yang; Xiaoqiu Wu; Yang Sun; Jianglin Li; Xiaoxiao Hu; Wei Lin; Dongmei Han; Yifan Zhao; Jing Liu; Mao Ye; Weihong Tan
Journal:  Oncotarget       Date:  2016-06-14

Review 10.  Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma.

Authors:  Rusdina Bte Ladju; Devis Pascut; Muhammad Nasrum Massi; Claudio Tiribelli; Caecilia H C Sukowati
Journal:  Oncotarget       Date:  2017-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.